CVS blows past estimates, hikes outlook as insurance business outperforms
A screen displays the logo and trading information for CVS at the New York Stock Exchange, March 24, 2026. Jeenah
Read More
Biotechnology
Major health insurers show signs of recovery – but a key test looms
Piotr Swat | SOPA Images | Lightrocket | Getty Images Major health insurers appear to be off to an encouraging
Read More
UnitedHealth tops quarterly estimates, hikes profit outlook as insurer manages high medical
UnitedHealthcare sign is displayed at its office building in Minnetonka, Minnesota, U.S., Dec. 11, 2025. Tim Evans | Reuters UnitedHealth
Read More
Novo Nordisk’s explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight
After years of trying to lose weight “the right way,” Jane Zuckerman realized that “putting in the work just wasn’t
Read More
Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to
Wegovy semaglutide tablets. Michael Siluk | Universal Images Group | Getty Images Novo Nordisk on Tuesday launched a multi-month subscription
Read More
FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4,
Read More
Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial
The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike Blake |
Read More
FDA approves leucovorin as first drug for rare genetic disorder, after touting it as autism
The Food and Drug Administration on Tuesday approved a decades-old prescription vitamin called leucovorin as the first treatment for a
Read More
Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4,
Read More
FDA chief warns U.S. is losing ground to China in early drug development, calls for faster
Food and Drug Administration Commissioner Marty Makary warned that the U.S. is falling behind China in early-stage drug development and
Read More